The market space for biopharmaceutical disposable consumables and equipment is broad, and pharmaceutical companies will usher in benefits

【Pharmaceutical Network Market Analysis】As the main direction of strategic emerging industries in China's "14th Five-Year Plan", biomedicine is an important support point
for promoting the construction of a healthy China.
It is worth noting that under the background of the rapid development of the biomedical industry, the market demand for upstream pharmaceutical equipment is expanding; The related consumables and equipment industry has also begun to make great progress
.
The market for disposable consumables and equipment is broad, and pharmaceutical companies will welcome the good (Image source: Pharmaceutical Network) It is understood that in the biological drug production cycle, the application of disposable products is becoming more and more extensive, and the demand is also rising
.
For example, in the process of pre-clinical and clinical sample production, disposable filters, disposable stirrers, disposable bioreactors and other equipment have
appeared.
Compared with traditional products such as stainless steel cans, market participants believe that disposable consumables and equipment are more flexible, not only can reduce the time-consuming and laborious cleaning verification in the pharmaceutical process, but also avoid cross-contamination between drug batches, and its unique high flexibility can realize the co-line production of multiple products, which can significantly improve the production capacity of enterprises and accelerate the launch of products, so there is a huge market space
.
At present, many domestic pharmaceutical equipment companies have begun to deploy disposable consumables and equipment
.
Among them, Chutian Technology said in an earlier announcement that the company has laid out disposable bioreactors, disposable dosing systems, ultrafiltration chromatography purification, stainless steel reactors and fillers
.
On February 16, 2022, Chutian Technology replied to investors on the investor interactive platform that the Shanghai factory of Chutiansiyote is currently under construction and is expected to be put into operation
within this year.
It is understood that Chutiansiyote Shanghai factory is a holding company
established by Chutian Technology.
On December 31, 2021, Chutian Technology issued a research activity announcement that in the field of disposable consumables, Chutian Technology has established Siyote, Chutian Siute has established a subsidiary in Shanghai, and is building a plant of about 6,000 square meters in Shanghai Lingang, which can achieve a production capacity of 200 million yuan after completion, which will be used for the development and production
of disposable bioreactors, liquid preparation bags, storage bags and their membranes.
In the future, with the commissioning of Chutian Siyote plant, the industry is expected to provide guarantee for the production capacity of Chutian Technology's disposable bioreactors, liquid preparation bags, storage bags and their membranes
.
Lepure Biotech is one of
the earliest local service providers in the field of biopharmaceutical disposable consumables and equipment.
In recent years, guided by scientific research and innovation, relying on Shanghai's leading biopharmaceutical industry cluster, and adhering to the R&D strategy of paying equal attention to basic materials and applications, it has achieved high-quality localization of a number of
key technologies and products.
For example, in March 2022, LepureBio has rushed to release three supporting disposable products for specific scenarios of cell and gene therapy (CGT), including cell breathable culture flasks, CCS cell rocking culture system (continuous culture swing bioreactor) and a set of cell closed automatic dispensing system and supporting consumables
.
In addition, Dongfulong is also one of the main R & D and production enterprises of disposable products in China, the company has been committed to the design, production and sales of various process consumables for single-use use in the biopharmaceutical process, including full-size disposable sterile bags, disposable lyophilized trays, disposable sterile filter materials, etc
。 At present, Dongfulong has formed a perfect consumables scheme in disposable bags (reaction bags\liquid preparation bags\storage bags), reagents (culture medium \ cryopreservation protection solution), fillers, filtration (microfiltration\deep \ultrafiltration\nanofiltration), and rigid packaging materials, forming a one-stop service capability of "instrument + equipment + consumables" to build high barriers and customer stickiness
.
In general, with the intensification of aging and the support of a series of favorable policies, China's biomedical industry is developing more and more rapidly, and the market scale is also expanding
.
In 2020, the size of China's biomedical market will be about 400 billion yuan
.
According to the Frost & Sullivan report, it is expected that by 2024, the size of China's biopharmaceutical market will exceed 100 billion US dollars
.
In this context, the industry expects that disposable consumables and equipment will also have broader development prospects in the biomedical industry, and related companies will also reap more benefits
.
Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice
to anyone.